1[1]Hantson L,Deweerdt W,De keyser J,et al. The European Stroke Scale[J]. Stroke,1994,25:2215-2219.
2[2]Memezawa H,Simith ML,Siesjo BK. Penumbral tissue salvaged by reperfusion following middle cerebral artery occlusion in rats[J]. Stroke,1992,23:552-567.
3[3]Del Zoppo GJ,Pessin MS,Mori E,et al. Thrombolytic intervention in acute thrombolic and embolic stroke[J]. Semin Neurol,1991,11:368-384.
4[4]The ECASS Study Grroup. Intravenous thrombolysis with recombinant tissue plasminogcn activator for acute hemispheric stroke[J]. JAMA,1995,274:1017-1025.
5[5]The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med,1995,333:1581-1592.
6[6]Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase,aspirin and combination of both in treatment of acute ischemic stroke[J]. Lancet,1995,346:1509-1514.
7Grotta JC,Welch KMA,Fagan SC,et al. Clinical deterioration following improvement in the NINDS rt-PA stroke trial [J].Stroke, 2001,32 : 661-668.
9Koennecke He ,Nohr R,Leistner S,et al. intravenous rtPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience[J]. Stroke, 2001,32 : 1074-1078.
10Lopez-Yunez AM, Bruno A, Williams LS, et al. Protocol violations in community-based rtPA stroke treatment are associated with symptomatic intracerebral hemorrhage[J]. Stroke, 2001,32 :12-16.
